Scleral band and vitrectomy in PVR

Arthur Cummings
Published: Thursday, September 17, 2015
Despite decreasing use of scleral buckling among retinal surgeons, combining it with vitrectomy is a very effective technique for the treatment of complex retinal detachment cases, Borja Corcóstegui MD, of the Instituto Microcirurgia Ocular, Barcelona, told delegates at the 15th EURETINA Congress in Nice, France.
Dr Corcóstegui was speaking during the instructional course in management of proliferative vitreoretinopathy (PVR). “The use of scleral buckling has vastly decreased in favour of primary vitrectomy for retinal detachment cases,” he said.
“There are various reasons for this transition from scleral buckling to vitrectomy, including simplified preoperative examination of patients, industry promotion of microincision vitrectomy and often higher reimbursement rates for vitrectomy. However, vitrectomy has several distinct disadvantages, such as cataract formation, subretinal perfluorocarbon, macular retinal folds and possibly increased long-term risk of glaucoma,” he added.
Despite this, retinal fellows are currently not offered a great deal of training in scleral buckling techniques, as vitrectomy has so many other indications, such as macular surgery and removal of vitreous haemorrhage.
“Several studies have suggested very variable results for the success rates of vitrectomy-only procedures for retinal detachments, so there is clearly room for improvement,” he said.
Dr Corcóstegui described the advantages of combining the two techniques to improve outcomes and decrease the chances of recurrent detachment.
“We know that it is currently impossible to remove all the vitreous gel from the vitreous base, but the addition of a scleral buckle helps support the base, reducing traction and thus the incidence of redetachment,” he said.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.